🇺🇸 FDA
Patent

US 11883420

Sting agonists for treating bladder cancer and solid tumors

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 11883420 (Sting agonists for treating bladder cancer and solid tumors) held by VENENUM BIODESIGN, LLC expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VENENUM BIODESIGN, LLC
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/519